Venture Capital
Breast cancer screening startup Niramai Health Analytix Pvt. Ltd has raised $6 million in a Series A round of funding led by Tokyo-headquartered management consulting firm Dream Incubator, a company statement said. Singapore-based venture fund Beenext and existing investors pi Ventures, Ankur Capital, Axilor Ventures and Binny Bansal also participated in the round, the statement added. The Bengaluru-based startup will use the fresh funds to scale its operations in India, hire top talent and get additional regulatory approvals for international expansion. Eto Munehiko, managing director of Dream Incubator Advisory and Investment India, will join the Niramai board, the statement added.

In this article